EMA
approval
· 2021-10-15
First-in-class medicine to treat aggressive form of breast cancer
Summary
EMA announces a first-in-class medicine approved to treat an aggressive form of breast cancer.
Upgrade for the full analysis, importance score, and drug timeline.